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Abstract
The role of mast cells (MCs) in Toxoplasma gondii infection is poorly known. Kunming outbred mice were infected
intraperitoneally with RH strain T. gondii, either treated with compound 48/80 (C48/80, MC activator) or disodium
cromoglycate (DSCG, MC inhibitor). Compared with infected controls, infected mice treated with C48/80 exhibited
significantly increased inflammation in the liver (P < 0.01), spleen (P < 0.05), and mesentery (P < 0.05) tissues,
higher parasite burden in the peritoneal lavage fluids (P < 0.01), and increased levels of mRNA transcripts of T.
gondii tachyzoite surface antigen 1 (SAG1) gene in the spleen and liver tissues (P < 0.01), accompanied with
significantly increased Th1 cytokine (IFN-γ, IL-12p40, and TNF-α) (P < 0.01) and decreased IL-10 (P < 0.01) mRNA
expressions in the liver, and increased IFN-γ (P < 0.01) and IL-12p40 (P < 0.01) but decreased TNF-α (P < 0.01) and
IL-4 (P < 0.01) in the spleens of infected mice treated with C48/80 at day 9-10 p.i. Whereas mice treated with DSCG
had significantly decreased tissue lesions (P < 0.01), lower parasite burden in the peritoneal lavage fluids (P < 0.01)
and decreased SAG1 expressions in the spleen and liver tissues (P < 0.01), accompanied with significantly
increased IFN-γ (P < 0.01) and IL-12p40 (P < 0.05) in the liver, and decreased IFN-γ (P < 0.05) and TNF-α (P < 0.01)
in the spleens; IL-4 and IL-10 expressions in both the spleen and liver were significantly increased (P < 0.01) in the
infected mice treated with DSCG. These findings suggest that mediators associated with the MC activation may play
an important role in modulating acute inflammatory pathogenesis and parasite clearance during T. gondii infection in
this strain of mice. Thus, MC activation/inhibition mechanisms are potential novel targets for the prevention and
control of T. gondii infection.
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Introduction
Toxoplasma gondii is a common and significant obligate
intracellular pathogen of humans and animals, which infects
nearly one third of the human population and is found in an
extraordinary range of vertebrate hosts [1]. The immune/
inflammatory response to T. gondii infection is essential to
control parasite replication and tissue spread but also can
cause tissue damage, being decisive to pathogenesis [2]. Mast
cells (MCs) are abundant in tissues exposed to the external
environment including the skin, intestinal tract, and trachea,
and also normally present in heart, lymph nodes, spleen, and
CNS [3]. Classically, MCs have been described as essential
effector cells of immediate hypersensitivity and chronic allergic
reactions that contribute to asthma, atopic dermatitis, and other
allergic diseases [4]. Recent findings indicate that MCs are
more functionally diverse than previously described. MCs play
a critical role in host defense against invading microbes and
participate in allergy as well as host defence against helminth
parasites [5,6]. Additionally, MCs play a role in many different
processes, and they are involved in responses against
pathogenic infections and most notably in connection with
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innate immune responses, wound healing, and inflammatory
disease [7]. Recent studies indicate that MCs are also involved
in immune regulation [8,9].
MCs are recognized as effector cells involved in clearance of
diverse parasites, including Trichinella spiralis and
Trichomonas vaginalis [10,11]. MC deficient mice infected with
Leishmania major develop larger lesion load with increased
parasitemia [12]. Although MCs are involved during the acute
phase of the inflammatory response to T. gondii infection in
animal model [13], the mechanism by which MC alter the
immune response during T. gondii infection has not been
resolved. In the present study, we assessed the role of MC
during acute murine T. gondii infection; our findings suggest
that release of mediators after MC activation plays an important
role in modulating inflammatory pathogenesis and parasite load
during acute T. gondii infection.
Materials and Methods
Ethics Statement
Female 6-week-old Kunming (KM, outbred) mice were
obtained from the Animal Center of Sun Yat-sen University,
maintained in specific-pathogen-free environment, and had free
access to a commercial basal diet and tap water ad libtum.
Animals were provided with humane care and healthful
conditions during their stay in the facility. All individuals who
use animals received instruction in experimental methods and
in the care, maintenance, and handling of mice; and all efforts
were made to minimize animal suffering. Animals were
sacrificed using CO2 asphyxiation and the appropriate organs
were harvested. The protocol in this study was approved by the
Committee on the Ethics of Animal Experiments of the Sun
Yat-sen University [Permit Numbers: SCXK (Guangdong)
2009–0011].
Parasite
T. gondii RH strain tachyzoites were propagated by
intraperitoneal (i.p.) passage in KM mice at 4 or 5 day intervals.
Mice were infected with 1×102 RH strain T. gondii tachyzoites
by i.p. injection, and tachyzoites were enumerated using
manual counting with a haemocytometer.
Mast cell (MC) activation and stabilization in vivo
Total 48 KM mice were included in this study. Mice were
divided into 6 groups, consisting of 7-9 mice per group.
Compound 48/80 (C48/80) activated the MCs and disodium
cromoglycate (DSCG) stabilized the MCs in mice. The model of
MC degranulation or stabilization used in the present study was
based on a well-characterized protocol with modifications [14].
Briefly, mice received the first i.p. injection of C48/80 (Sigma-
Aldrich, 4 mg/kg/d) or DSCG (Sigma-Aldrich, 25 mg/kg/d) 24 h
before infection with T. gondii RH strain tachyzoites, and each
animal received daily i.p. injection for the duration of the
experiment thereafter [9-10 days post infection (p.i.)]. C48/80
enhanced MCs releasing their mediators and DSCG prevented
MCs from releasing their mediators for the duration of the
experiment. Infected control mice were infected with T. gondii
RH strain tachyzoites alone without any treatment. Uninfected
controls were received injections with either the phosphate-
buffered saline (PBS) diluent, C48/80, or DSCG.
Histopathological analysis
Mice were sacrificed by CO2 asphyxiation prior to death after
infection, and their livers, spleens, and mesenteries were
harvested and immediately fixed in 10% buffered natural
formaldehyde (Guangzhou chemical reagent factory, China).
Four-micrometer-thick sections (50- or 100-μm distance
between sections) of the organ from each mouse, stained with
hematoxylin and eosin (H&E) (Sigma-Aldrich), were evaluated
for histological changes. Blinded samples were submitted for
semi-quantitative histopathologic analysis. The histological
scores in the spleen and mesentery tissues were determined
under ×100 magnification in three non-contiguous sections
from four mice in each group. In brief, the score used to
measure the intensity of spleen and mesentery tissue
alterations was 1, 2, 3, and 4 (absent, mild, moderate, and
severe, respectively) [15]. Liver sections were analyzed for the
numbers of inflammatory foci according to previous report with
minor modifications [2], and the number of inflammatory foci
per field was analyzed at a magnification of ×100 under a light
microscopy by counting 10 fields of each section at 9-10 days
p.i. in each group. All the analyses were performed by two
researchers.
Toluidine blue staining for MCs
Serialized 4-μm-thick sections of spleen and mesentery were
deparaffinized, rehydrated, and stained with 0.5% toluidine
blue (Sigma-Aldrich) for 120 min. MCs, in three to five sections
per animal on days 9 to 10 after treatment, were identified by
their deep blue-purple staining and counted at ×400
magnification under light microscopy. MC count was expressed
as the number of positive cells per mm2 and the results were
expressed as the mean value of MCs per group. MC
degranulation was determined as a loss of MC membrane
integrity with extrusion of intracellular granules to the
extracellular space or MCs completely lacking in intracellular
granules as described previously [16]. Completely
degranulated MCs with absence of the cytoplasmic granules
are invisible by toluidine blue staining.
Immunofluorescence staining of tryptase for MCs
  Spleen and mesentery tissue sections (4-μm) were
deparaffinized and rehydrated in distilled water. Heat-induced
antigen retrieval was carried out in an 800-W microwave oven
for 30 min. Endogenous peroxidase activity was blocked by
incubation with 0.3 % hydrogen peroxide in methanol for 10
min at room temperature. Non-specific binding was blocked by
incubation in PBS containing 10 % normal goat serum and 1 %
bovine serum albumin (BSA) (pH 7.4) for 60 min at room
temperature. Sections were incubated with anti-MC tryptase
mouse monoclonal antibody (AA1, IgG1; 1 mg/ml, 1:200
dilution; Abcam, USA) overnight at 4°C. Slides were then
rinsed three times with PBS (pH 7.4) and exposed to
secondary antibody [anti-mouse IgG (H+L), F (ab') 2 fragment
(Alexa Fluor® 488 Conjugate); 2 mg/ml, 1:200 dilution; CST,
Mast Cells Modulate Acute Toxoplasmosis
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USA] for 60 min at room temperature in a dark chamber. The
slides were washed three times with PBS (pH 7.4) for 30 min at
room temperature and mounted by antifade
polyvinylpyrrolidone mounting medium (Beyotime, China) in a
dark chamber. MCs were identified by their green fluorescence
staining and counted at ×400 magnifications under a light
microscope. Positively stained MCs were counted and
expressed as mentioned above.
T. gondii tachyzoite burden in mouse peritoneal lavage
fluids
To examine the effect of C48/80 or DSCG on the parasite
proliferation in vivo, we examined parasite burden in mouse
peritoneal lavage fluids infected with T. gondii with either
C48/80 or DSCG treatment, or without treatment. Mice were
killed at 9-10 days p.i. prior to death after infection, the
peritoneal lavage fluids of each mouse was passed through a
27 gauge needle, and the parasite numbers were counted by
hemocytometer.
Measurement of mRNA expression in spleen and liver
tissues using quantitative real-time PCR (qRT-PCR)
Total RNA was extracted from about 100 mg spleen or liver
sample each mouse using RNA extraction kit (TaKaRa, Japan)
according to the manufacturer’s protocol. The quality of total
RNA was analyzed by running 5 μl of each RNA sample on a
1.0% agarose gel and visualizing with ethidium bromide. The
quantity of total RNA was estimated by measuring the
absorbance at 260 nm and 280 nm using a NanoDrop 2000
spectrophotometer (NanoDrop Technologies). First-strand
cDNA was constructed from 1.0 μg of total RNA with oligo (dT)
as primers using PrimeScript 1st Strand cDNA Synthesis Kit
(TaKaRa), following the manufacturer’s protocol. cDNA was
stored at −80 °C until use.
To determine the levels of mRNA transcripts of T. gondii
tachyzoite surface antigen 1 (SAG1) gene and cytokines
including IFN-γ, TNF-α, IL-4, IL-10, and IL-12p40 in both
spleen and liver tissues from different groups of mice, qRT-
PCR was performed using SYBR Green qPCR Master Mix
(TaKaRa) according to manufacturer’s instructions. Primers are
listed in Table 1. Briefly, the total 10 μl reaction mixture
contained 5.0 μl of SYBR® Premix Ex TaqTM (2×), 0.5 μl of each
primer (10 pM), 3.0 μl of dH2O, and 1.0 μl of cDNA (0.2 μg/μl).
The thermal cycling conditions consisted of an initial
denaturation of 30 sec at 95°C followed by 43 cycles of 95°C
for 5 sec and 60°C for 20 sec. Values are means from triplicate
measurements, specific mRNA expression levels were
normalized to the housekeeping gene β-actin mRNA and the
results are expressed as the fold change compared to
uninfected controls.
Statistical Analysis
Data are expressed as means ± SEM. All of the pathological
measurements were done in a blind fashion, and the
quantitative measurements were made twice. A statistical
software program SPSS 17.0 was applied for analysis.
Differences of histopathological examination in liver, spleen,
and mesentery between different groups were investigated
using the Kruskal-Wallis rank sum test. The fold changes of
SAG1 and cytokine mRNA expressions were analyzed by




The survival rates and survival times of the infected mice
from different groups were similar, and all the RH strain T.
gondii-infected mice with either C48/80 or DSCG treatment, or
without treatment died within 9-10 days p.i. (Figure 1).
MC activation and stabilization
Stained with toluidine blue, MCs were identified in tissue
sections from their characteristic granular, deep blue-purple
metachromatic appearance against blue orthochromatic
background tissue. Toluidine blue stained sections of the
mesenteries and spleens from different groups at 9-10 days p.i.
were shown in Figures 2 and 3, respectively. Stained with
immunofluorescence for tryptase, MCs from their characteristic
green fluorescence were identified in tissue sections of the
mesenteries and spleens from different groups at 9-10 days p.i.
(Figures 4 and 5, respectively). MCs were intact in uninfected
mice with PBS treatment (Figures 2a, 3a, 4a, and 5a); MCs
had mild or obvious granula release (Figures 2b, 3b, 4b, and
5b) in T. gondii-infected control mice. However, MCs had
marked granule release in uninfected (Figures 2c, 3c, 4c, and
5c) and T. gondii-infected mice (Figures 2d, 3d, 4d, and 5d)
with C48/80 treatment. MCs were intact in uninfected (Figures
2e, 3e, 4e, and 5e) and T. gondii-infected mice (Figures 2f, 3f,
4f, and 5f) with DSCG treatment, and the latter appeared
morphologically indistinguishable from the uninfected controls.
Table 1. Primer sequences of mouse target cytokines and
housekeeping genes used for quantitative real-time
polymerase chain reaction (qRT-PCR) assays.
Genes Primer sequence (5′→3′) References
IFN-γ Forward primer GGAACTGGCAAAAGGATGGTGAC [42]
 Reverse primer GCTGGACCTGTGGGTTGTTGAC  
TNF-α Forward primer CCCTCACACTCAGATCATCTTCT [43]
 Reverse primer GCTACGACGTGGGCTACAG  
IL-4 Forward primer ACAGGAGAAGGGACGCCAT [44]
 Reverse primer GAAGCCCTACAGACGAGCTCA  
IL-10 Forward primer AGCCGGGAAGACAATAACTG [42]
 Reverse primer CATTTCCGATAAGGCTTGG  
IL-12p40 Forward primer CCTGGTTTGCCATCGTTTTG [42]
 Reverse primer TCAGAGTCTCGCCTCCTTTGTG  
SAG1 Forward primer CTGTCAAGTTGTCTGCGGAAGGAC [42]
 Reverse primer CGTTAGCGTGGCACCATTATCACTC  
β-actin Forward primer TGGAATCCTGTGGCATCCATGAAAC [42]
 Reverse primer TAAAACGCAGCTCAGTAACAGTCCG  
doi: 10.1371/journal.pone.0077327.t001
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Spleen MC densities
MC count was assessed by examining sections of spleen
tissues by both metachromatic staining with toluidine blue and
immunofluorescence staining of tryptase. As shown in Figure 6,
there were only a low density (the number of MCs per mm2)
positively stained MCs with undegranulation observed in the
spleen tissues of uninfected mice treated with PBS, while there
were significantly higher densities of MCs in T. gondii-infected
control mice. In uninfected mice, C48/80 administration did not
change the number of MCs; while DSCG administration
increased the MC density in the spleens by 3.1 fold by toluidine
blue staining (P < 0.01) and 1.8 fold by immunofluorescence
staining of tryptase (P < 0.01) relative to that in uninfected mice
with PBS. T. gondii infection increased the density of MCs by
4.0 fold by toluidine blue staining (P < 0.01) and 1.7 fold by
immunofluorescence staining of tryptase (P < 0.01) relative to
that in uninfected mice with PBS. In contrast, in T. gondii-
infected mice that received C48/80, the density of MCs was no
change by both staining, whereas in T. gondii-infected mice
that received DSCG, the density of MCs was increased by 13.0
fold by toluidine blue staining (P < 0.01) and 4.6 fold by
immunofluorescence staining of tryptase (P < 0.01) relative to
that in uninfected mice with PBS. Compared with toluidine blue
staining, there were significantly higher MC densities in spleen
tissues in all the groups when using immunofluorescence
staining of tryptase (P < 0.01). C48/80 treatment of the spleens
degranulated MCs, which resulted in a lack of both toluidine
blue staining of granule matrix proteoglycans and
immunofluorescence staining of tryptase. However, it is
important to notice that not all MCs were degranulated or
undegranulated by these treatments.
Severe liver, spleen, and mesentery inflammation in T.
gondii-infected mice with C48/80 treatment
To investigate the effects of the mediators released by MCs
on tissue pathological changes, the liver (Figure 7A), spleen
(Figure 8A), and mesentery (Figure 9A) tissues from different
groups were examined histological. Control sections of liver
(Figures 7a and b), spleen (Figure 8a), and mesentery (Figure
9a) from uninfected mice treated with PBS were negative for
both inflammation and necrosis foci and T. gondii staining.
After primary i.p. T. gondii RH strain infection, severe damage
(obvious inflammation and necrosis foci) and a great number of
RH tachyzoites were observed in the liver (Figure 7c and d),
spleen (Figure 8b), and mesentery (Figure 9b) tissues of
infected control mice. In comparison, even severer damage
(stronger inflammation and more necrosis foci) and a greater
number of RH tachyzoites were observed in the liver (Figure 7e
and f), spleen (Figure 8c), and mesentery (Figure 9c) tissues of
T. gondii-infected mice treated with C48/80; whereas
attenuated or moderate histological evidence (mild
inflammation and fewer necrosis foci) and a lower number of
RH tachyzoites were observed in the liver (Figure 7g and h),
spleen (Figure 8d) and mesentery (Figure 9 d) tissues of T.
gondii-infected mice treated with DSCG. Treatment with
C48/80 or DSCG did not change the tissue histology from
Figure 1.  Mice survival after infection with 102 RH tachyzoites of T.  gondii.
Survival of naïve mice treated with PBS (open square, n=8); uninfected mice treated with C48/80 (dash, n=8); uninfected mice
treated with DSCG (open upright triangle, n=8); T. gondii-infected control mice (filled square, n=7), T. gondii-infected mice with
C48/80 treatment (asterisk, n=9), and T. gondii-infected mice with DSCG treatment (filled upright triangle, n=8). The mice were
monitored for survival on a daily basis until the termination of the experiment.
doi: 10.1371/journal.pone.0077327.g001
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uninfected mice, comparing with that of uninfected mice
received PBS (data not shown).
Quantitative analysis of the severity of inflammation and
necrosis of liver sections (e.g. the number of inflammatory foci
per field, 3 slides/animal) of different groups of mice was
performed (Figure 7B). A great number of inflammatory foci of
neutrophil infiltrates were observed in the liver of T. gondii-
infected control mice. In comparison, significantly increased
inflammatory foci of neutrophil infiltrates were observed in the
T. gondii-infected mice with C48/80 treatment (P < 0.01),
whereas significantly reduced inflammatory foci of neutrophil
infiltrates were observed in the T. gondii-infected mice with
DSCG treatment (P < 0.01). Semiquantitative histological
evaluation of spleen (Figure 8B) and mesentery (Figure 9B)
sections (3 slides/animal) of different groups of mice were
performed. Severe pathology was shown in the spleen and
mesentery tissues of T. gondii-infected mice without treatment.
In comparison, even severer pathology were shown in the
spleen and mesentery tissues of T. gondii-infected mice with
C48/80 treatment (P < 0.05); whereas attenuated pathology
were shown in the spleen and mesentery tissues of infected
mice with DSCG treatment (P < 0.01).
Increased parasite burden in T. gondii-infected mice
with C48/80 treatment
To investigate whether MC activation and degranulation are
important in host defense, live T. gondii tachyzoites were
recovered from the peritoneal lavage fluids of infected mice
with either C48/80 or DSCG treatment, or without treatment at
9-10 days p.i when mice were becoming moribund, and
counted by hemocytometer (Figure 10A). Compared with T.
gondii-infected control mice, there was a significant increase
(2.3-fold) in the number of T. gondii tachyzoites in the
peritoneal lavage fluids of infected mice treated with C48/80
(P < 0.01), whereas there was a significant decrease (2.1-fold)
in the number of T. gondii tachyzoites in that of mice treated
with DSCG (P < 0.01). In addition, a significant decrease (4.8-
fold) in the number of T. gondii tachyzoites from infected mice
treated with DSCG in comparison with that from infected mice
Figure 2.  Light photomicrographs of metachromatic MCs in mesenteries by toluidine blue staining.  Infected mice i.p.
inoculated with 102 RH tachyzoites of T. gondii from different groups were killed at 9-10 days p.i. Metachromatic MCs were
evaluated in mesentery tissue from uninfected mouse treated with PBS (a), infected control mouse displaying mildly degranulated
MCs (b), uninfected mouse treated with C48/80 (c) and infected mouse treated with C48/80 (d), both displaying degranulated MCs
(arrows); uninfected mouse treated with DSCG (e) and infected mouse treated with DSCG (f), both displaying intact MCs.
doi: 10.1371/journal.pone.0077327.g002
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treated with C48/80 (P < 0.01). To confirm the parasite burden
of T. gondii tachyzoite in tissues, qRT-PCR was performed to
determine the levels of mRNA transcripts for tachyzoite SAG1-
stage specific gene in both liver and spleen tissues from
different groups of mice at 9-10 days p.i (Figure 10B).
Compared with T. gondii-infected controls, there was a
significantly increased mRNA transcripts for SAG1 in both liver
(P < 0.01) and spleen (P < 0.01) of infected mice treated with
C48/80, whereas there was a significantly decreased mRNA
transcripts for SAG1 in both liver (P < 0.01) and spleen
(P < 0.01) of infected mice treated with DSCG (P < 0.01).
Th1 and Th2 mRNA cytokine responses in the spleen
and liver of different groups
The effect of MC mediator release on Th1 and Th2 cytokine
responses after T. gondii infection was evaluated by measuring
IFN-γ, IL-12p40, TNF-α, IL-4, and IL-10 mRNA expressions in
the spleens (Figure 11) and livers (Figure 12) of different
groups. Cytokine mRNA expressions in naïve mice were not
altered by C48/80 or DSCG treatment itself. However,
compared with uninfected mice treated with PBS, there were
significantly increased mRNA expressions of IFN-γ, IL-12p40,
TNF-α, IL-4, and IL-10 in the livers and spleens of T. gondii-
infected control mice at days 9-10 p.i. (P < 0.01), using qRT-
PCR. Compared with T. gondii-infected controls, the Th1
cytokine (IFN-γ, IL-12p40, and TNF-α) expressions were
significantly increased (P < 0.01) and the Th2 cytokine (IL-10)
was significantly decreased (P < 0.01) in the livers, and the
expressions of IFN-γ (P < 0.01) and IL-12p40 (P < 0.01) were
significantly increased but TNF-α (P < 0.01) and IL-4 (P < 0.01)
were significantly decreased in the spleens of infected mice
treated with C48/80 at day 9-10 p.i. Whereas the expressions
of Th1 cytokine [IFN-γ (P < 0.01) and IL-12p40 (P < 0.05)] were
significantly increased in the liver, and IFN-γ (P < 0.05) and
TNF-α (P < 0.01) were significantly decreased in the spleens of
the infected mice treated with DSCG at day 9-10 p.i. However,
the Th2 cytokine (IL-4 and IL-10) expressions in both spleen
and liver were significantly increased (P < 0.01) in the infected
mice treated with DSCG.
Figure 3.  Light photomicrographs of metachromatic MCs in spleens by toluidine blue staining.  Infected mice i.p. inoculated
with 102 RH tachyzoites of T. gondii from different groups were killed at 9-10 days p.i. Metachromatic MCs (arrows) were evaluated
in spleen tissue from uninfected mouse treated with PBS (a), infected control mouse displaying a degranulated MC (b), uninfected
mouse treated with C48/80 (c) and infected mouse treated with C48/80 (d), both displaying degranulated MCs; uninfected mouse
treated with DSCG (e) and infected mouse treated with DSCG, both displaying intact MCs (f).
doi: 10.1371/journal.pone.0077327.g003
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Discussion
Toxoplasmosis, an inflammatory disease, can lead to severe
pathology in both humans and animals, involves leukocyte
recruitment, immune responses, and inflammatory cytokine
production, and immunity to infection relies on the development
of a strong cell-mediated immune response, such as T cells
and the production of IFN-γ [17,18]. It has been reported that a
significant increase in the number of MCs in animals inoculated
either i.p. or via the conjunctiva with T. gondii tachyzoites has
been observed previously [19]. After incubation with T. gondii in
vitro, peritoneal lavage MCs of Sprague-Dawley rats were
found to degranulate and release LTB4, which damage T.
gondii tachyzoites [20]. Despite these observations, little is
known about the relationship between MCs and pathogenesis
of T. gondii infection, as well as the MCs mediators generated
in response to T. gondii infection. KM mice are the most widely
used outbred colony in China. Using this murine model of T.
gondii infection in the present study, we show here that the
activation of MCs in mice via C48/80 injection resulted in
increased T. gondii load and enhanced inflammatory infiltrate,
whereas the MC stabilization with DSCG diminished T. gondii
 load and attenuated inflammatory reaction. Our data
demonstrate that MCs play a crucial role in the course of T.
gondii infection.
In this study, our data demonstrated that infection with T.
gondii not only increased the number of MCs in the analyzed
tissues but also induced noticeable MC degranulation at 9-10
days p.i., by both toluidine blue staining and
immunofluorescence staining of tryptase. As it has been
reported that immunohistochemical staining for tryptase is a
highly specific and sensitive method for identifying MCs [21],
we also found MC density was significantly higher with
immunofluorescence staining of tryptase compared with that of
toluidine blue staining, due to the strong immunofluorescence
staining of both intact and degranulated MCs. MC activation
and degranulation most commonly result from multivalent
antigens binding to the IgE bound to the high-affinity IgE
receptor (FcεRI) on the surface, which results in noncytotoxic
degranulation and the release of a variety of preformed and
newly synthesized mediators [22]. The degranulation of MCs
observed in T. gondii-infected animals is probably due to the
presence of excreted-secreted antigens from T. gondii in
tissues [23]. The C48/80 has been used to study allergies and
Figure 4.  Light photomicrographs of tryptase positive-MCs in mesenteries by immunofluorescence staining.  Infected mice
i.p. inoculated with 102 RH tachyzoites of T. gondii from different groups were killed at 9-10 days p.i. MCs were evaluated in
mesentery tissue from uninfected mouse treated with PBS (a), infected control mouse displaying a degranulated MC (arrow) (b),
uninfected mouse treated with C48/80 (c) and infected mouse treated with C48/80 (d), both displaying degranulated MCs (arrows);
uninfected mouse treated with DSCG (e) and infected mouse treated with DSCG (f), both displaying intact MCs.
doi: 10.1371/journal.pone.0077327.g004
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anaphylaxis, because it can vigorously activate the release of
histamine via the mechanism of cellular exocytosis [24]. In vivo
studies have shown that C48/80 is a potent activator of MCs
[25], a receptor mimetic that directly activates G proteins and
stimulates vigorous MC degranulation, and releasing MC
mediators independently of FcεRI activation [26]. Thus, C48/80
has been widely used to degranulate MCs in live animals. To
determine whether regulation of MC activation controls acute
toxoplasmosis, we injected C48/80 into T. gondii-infected mice
before infection with T. gondii, and mice received daily injection
of C48/80 during the experiment. Thus, MCs are repeatedly
stimulated to release mediators under the conditions used in
the present study. Compared with infected controls, in T.
gondii-infected mice with C48/80 treatment, the presence of
normal numbers of degranulated MCs containing granules at
the site of infection with T. gondii correlates with the
development of severer pathology, which presented as
significantly more inflammation sites or higher pathological
scores. Pharmacological treatment of mice with C48/80 triggers
MC activation and the release of preformed mediators such as
histamine, tryptase, chemokines, and interleukins that are
important in the initial events of the inflammatory response [27].
DSCG is a drug widely used in the treatment of asthmatic
patients [28], and observations from in vitro tests and animal
models show that the effect of DSCG is related to MC
stabilization [14]. DSCG prevents MC degranulation and acts
as antiinflammatory agent [29], and the effect of DSCG is due
to its ability to stabilize the MC membrane and to prevent
release of histamine and inflammatory mediators. In the current
study, compared with infected controls, there were significantly
increased MC numbers in the spleens, accompanied with
significantly impaired pathogenesis of T. gondii infection in the
analyzed tissues of the infected mice with DSCG treatment.
Our data suggest that mediators released by MCs results in
impairment of T. gondii clearance and reduced MC
degranulation limits pathogenesis caused by T. gondii infection,
which indicates that MC activation/inhibition mechanisms are
potential novel targets for T. gondii infection prevention and
control.
It is well known that activated MCs synthesize and release a
large number of cytokines and chemokines [30]. To directly
evaluate the in vivo role of MCs in acute murine toxoplasmosis,
the effect of MC mediator release on Th1 and Th2 cytokine
responses was evaluated in the spleens and livers in different
Figure 5.  Light photomicrographs of tryptase positive-MCs in spleens by immunofluorescence staining.  Infected mice i.p.
inoculated with 102 RH tachyzoites of T. gondii from different groups were killed at 9-10 days p.i. MCs were evaluated in spleen
tissue from uninfected mouse treated with PBS (a), infected control mouse displaying degranulated MCs (arrows) (b), uninfected
mouse treated with C48/80 (c) and infected mouse treated with C48/80 (d), both displaying degranulated MCs (arrows); uninfected
mouse treated with DSCG (e) and infected mouse treated with DSCG (f), both displaying intact MCs.
doi: 10.1371/journal.pone.0077327.g005
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groups. Importantly, increased pathogenesis of T. gondii
infection, accompanied with enhanced mRNA expressions of
Th1 cytokine (IFN-γ, IL-12p40, or TNF-α), and decreased Th2
cytokine (IL-4 or IL-10) in liver and spleen in C48/80-treated
mice, suggesting that C48/80 promotes MC activation or
degranulation and thereby affects the release of MC mediators.
MC degranulation produces the initial signals responsible for
regulating neutrophil and mononuclear cell recruitment in the
bronchoalveolar space through release of both pro- and
antiinflammatory mediators [27]. Activation of MCs and the
subsequent release of their granular constituents is a major
mechanism whereby MCs participate in pathobiological
processes [31]. These findings suggest that release of
mediators after MC activation plays an important role in
modulating acute inflammation during T. gondii infection. MCs
likely affect pathogenesis of T. gondii infection by up-regulating
the expressions of Th1 cytokine (IFN-γ, IL-12p40, or TNF-α),
and down-regulating the expressions of Th2 cytokine (IL-4 or
IL-10), but other unmeasured mediators may also involve this
process. Whereas infected mice treated with DSCG, the
expressions of Th1 cytokine (IFN-γ or TNF-α) were significantly
decreased and Th2 cytokine (IL-4 and IL-10) were significantly
increased in the spleens or livers. IL-4 is the main promoter of
type-2 responses and is classically reported as counter-
regulating type-1 immunity [32], and IL-10 plays a vital role in
controlling the inflammatory response during acute T. gondii
infection [33]. In the course of toxoplasmosis in patients, the
level of IL-10 is five-fold higher than that in healthy controls;
however, the levels of IL-12 and TNF-α are comparable to
those observed in healthy controls [34]. MCs and MC-derived
IL-10 limit leukocyte infiltration, inflammation, and tissue
damage associated with immunological or innate responses
[9]. Histamine, the main preformed mediator stored in MC
granules, stimulates alveolar macrophages to release
neutrophil and monocyte chemotactic factors [27]. In the
present study, the role played by MCs in neutrophil recruitment
in analyzed tissues may be attributed to the consequence of a
reduction in the expressions of IL-4 or IL-10 at the site of the
infection in infected mice with C48/80 treatment. In addition,
the results presented here may also be due to an indirect effect
of the release of mediators by MCs on the production and
release of cytokines and chemokines by other cells. MCs have
been proposed to be an important source of TNF [35].
However, MCs do not contribute to the rapid appearance of
TNF in the serum of LPS-treated mice [36]. Our data showed
that MCs contribute significantly to local (the liver tissue) TNF-α
production in this experimental model.
IFN-γ-mediated immune responses are essential for
controlling tachyzoite proliferation during both acute acquired
infection and reactivation of infection in the brain [37], and IFN-
γ has also been demonstrated to regulate the T. gondii load
and interconversion in the eye [38]. However, there were
increased IFN-γ mRNA expressions in both livers and spleens
in mice treated with C48/80 in this study, thus, the inability to
control T. gondii replication observed in mice treated with
C48/80 seems not to be a consequence of an increase in the
expression of IFN-γ. IL-4 is protective against development of
TE by preventing formation of T. gondii cysts and proliferation
of tachyzoites in the brain [39]. In this study, there were
significantly decreased levels of IL-4 and IL-10 in spleen and
liver, respectively, from mice treated with C48/80. It has been
reported that IL-10 limits parasite burden in murine
Figure 6.  The numbers of metachromatic and tryptase-positive MCs in spleen tissues from different groups expressed as
MCs mm−2.  There were 4 mice per group, and the data are representative of two experiments. Statistically significant differences
for comparison with the uninfected mice with PBS (**, P < 0.01) and for comparison with the infected controls (§, P < 0.01).
doi: 10.1371/journal.pone.0077327.g006
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Figure 7.  The liver histological analysis of T.  gondii-infected mice from different groups.
Infected mice i.p. inoculated with 102 RH tachyzoites of T. gondii were killed at 9-10 days p.i. (A) Representative microscopic
pictures show sections from uninfected mouse treated with PBS (a and b), infected control mouse (c and d), infected mouse treated
with C48/80 (e and f), and infected mouse treated with DSCG (g and h). Tachyzoites were indicated with arrows. H&E stain. (B)
Quantitative analysis of the number of inflammatory foci per field in liver sections from different groups. There were 4 mice per
group, and the data are representative of two experiments. *, P < 0.05; **, P < 0.01 (compared to control).
doi: 10.1371/journal.pone.0077327.g007
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Trypanosoma cruzi infection [40], and IL-10 mRNA levels
directly correlate with parasite load in lesions tissues of post
kala azar dermal leishmaniasis patients [41]. This finding
suggests that mediators released by C48/80-treated MCs result
in impairment of T. gondii clearance, which may be related to
the decreased IL-4 or IL-10 levels; whereas infected mice
treated with DSCG result in lower parasite burden, which may
be related to the increased IL-4 and IL-10 levels in this model.
Our data indicated that MC activation is important in the
regulation of the inflammatory response to host defense
against T. gondii infection, and the cellular immune response
may be partially impaired in infected mice treated with C48/80,
which is crucial to the destruction and elimination of T. gondii.
We cannot outline the mechanism increasing the parasite
burden in acute toxoplasmosis with C48/80 treatment in the
current study; however, the fact that it involves MCs
degranulation brings new aspect of the problem. In addition, we
found that the levels of T. gondii -specific IgG were no
differences among the infected groups (data not shown), which
suggested that the administration of either C48/80 or DSCG
does not change the humoral immunity during acute T. gondii
infection.
In summary, this study showed that MC stimulator were able
to deteriorate the pathology and increase parasite burden in T.
gondii-infected mice with C48/80 treatment; whereas MC
stabilizers were able to improve the pathology and decrease
parasite burden in T. gondii-infected mice with DSCG
treatment. Our data indicate that MCs contribute to
susceptibility and systemic inflammation during acute murine T.
gondii infection through the production and secretion of
mediators including cytokines that play a role in the recruitment
and activation of inflammatory cells in this experimental model,
and these findings propose a novel mechanism that MCs play
important roles for host immunity against T. gondii infection.
Figure 8.  The spleen histological analysis of T.  gondii-infected mice from different groups.
Infected mice i.p. inoculated with 102 RH tachyzoites of T. gondii were killed at 9-10 days p.i. (A) Representative microscopic
pictures show sections from uninfected mouse treated with PBS (a), T. gondii-infected control mouse (b), T. gondii-infected mouse
treated with C48/80 (c), and T. gondii-mouse treated with DSCG (d). Tachyzoites were indicated with arrows. H&E stain. (B)
Histological score analysis of spleen tissues. There were 4 mice per group, and the data are representative of two experiments. *, P
< 0.05; **, P < 0.01 (compared to control).
doi: 10.1371/journal.pone.0077327.g008
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Figure 9.  The mesentery histopathology of T.  gondii-infected mice from different groups.
Infected mice i.p. inoculated with 102 RH tachyzoites of T. gondii were killed at 9-10 days p.i. (A) Representative microscopic
pictures show sections from uninfected mouse treated with PBS (a), T. gondii-infected control mouse (b), T. gondii-infected mouse
treated with C48/80 (c), and T. gondii-infected mouse treated with DSCG (d). Tachyzoites were indicated with arrows. H&E stain.
(B) Histological score analysis of mesentery tissues. There were 4 mice per group, and the data are representative of two
experiments. *, P < 0.05; **, P < 0.01 (compared to control).
doi: 10.1371/journal.pone.0077327.g009
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Figure 10.  Parasite burden of T.  gondii RH strain tachyzoites in the peritoneal lavage fluids and tissues.
(A) Parasite burden of T. gondii RH strain tachyzoites in the peritoneal lavage fluids and (B) normalized mRNA expression levels of
T. gondii tachyzoite SAG1 gene in the spleens and livers using qRT-PCR, from different groups i.p. inoculated with 102 T. gondii RH
strain tachyzoites at 9-10 days p.i. There were 4 mice per group, and the data are representative of two experiments. Symbols
indicate statistically significant differences (P < 0.01) for comparison with the uninfected controls (**) and for comparison between
group means (§).
doi: 10.1371/journal.pone.0077327.g010
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Figure 11.  Cytokine mRNA expressions in spleens from different groups i.p inoculated with 102 T.  gondii RH strain
tachyzoites at 9-10 days p.i., using qRT-PCR.
There were 4 mice per group, and the data are representative of two experiments. Symbols indicate statistically significant
differences (P < 0.01) for comparison with the uninfected control mice (**) and the infected controls (§), and statistically significant
differences (P < 0.05) for comparison with the infected controls (#).
doi: 10.1371/journal.pone.0077327.g011
Figure 12.  Cytokine mRNA expressions in livers from different groups i.p. inoculated with 102 T.  gondii RH strain
tachyzoites at 9-10 days p.i., using qRT-PCR.
There were 4 mice per group, and the data are representative of two experiments. Symbols indicate statistically significant
differences (P < 0.01) for comparison with the uninfected control mice (**) and the infected controls (§), and statistically significant
differences (P < 0.05) for comparison with the infected controls (#).
doi: 10.1371/journal.pone.0077327.g012
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